Cargando…

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains

The ongoing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic had brought disastrous consequences throughout the entire world. While several manufactured vaccines have been approved for emergency use, continuous efforts to generate novel vaccines are needed. In this study, we dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Ki-Back, Kang, Hae-Ji, Yoon, Keon-Woong, Lee, Hae-Ahm, Moon, Eun-Kyung, Han, Beom-Ku, Quan, Fu-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402567/ https://www.ncbi.nlm.nih.gov/pubmed/34452044 http://dx.doi.org/10.3390/vaccines9080920

Ejemplares similares

Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization
por: Kang, Hae-Ji, et al.
Publicado: (2021)

Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Histone Deacetylase Inhibitor-Induced CDKN2B and CDKN2D Contribute to G2/M Cell Cycle Arrest Incurred by Oxidative Stress in Hepatocellular Carcinoma Cells via Forkhead Box M1 Suppression
por: Lee, Hae-Ahm, et al.
Publicado: (2021)

Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection
por: Kang, Hae-Ji, et al.
Publicado: (2021)

Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
por: Kim, Min-Ju, et al.
Publicado: (2022)

Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice
por: Mao, Jie, et al.
Publicado: (2022)

Glutathione Peroxidase 8 Suppression by Histone Deacetylase Inhibitors Enhances Endoplasmic Reticulum Stress and Cell Death by Oxidative Stress in Hepatocellular Carcinoma Cells
por: Lee, Hae-Ahm, et al.
Publicado: (2021)

Preliminary Trichinella spiralis Infection Ameliorates Subsequent RSV Infection-Induced Inflammatory Response
por: Chu, Ki-Back, et al.
Publicado: (2020)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Identification of differentially expressed Legionella genes during its intracellular growth in Acanthamoeba
por: Quan, Fu-Shi, et al.
Publicado: (2020)

Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection
por: Kim, Min-Ju, et al.
Publicado: (2022)

Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein
por: Eom, Gi-Deok, et al.
Publicado: (2023)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei
por: Kim, Min-Ju, et al.
Publicado: (2022)

The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
por: Kang, Hae-Ji, et al.
Publicado: (2023)

Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis
por: Park, So-Min, et al.
Publicado: (2020)

Chorismate mutase peptide antibody enables specific detection of Acanthamoeba
por: Lee, Hae-Ahm, et al.
Publicado: (2021)

Detection of Acanthamoeba spp. using carboxylesterase antibody and its usage for diagnosing Acanthamoeba-keratitis
por: Kim, Min-Jeong, et al.
Publicado: (2022)

Influenza vaccine efficacy induced by orally administered recombinant baculoviruses
por: Basak, Swarnendu, et al.
Publicado: (2020)

Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021)

Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18
por: Yoon, Keon-Woong, et al.
Publicado: (2022)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection
por: Yoon, Keon-Woong, et al.
Publicado: (2022)

Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Recombinant Vaccinia Virus Expressing Plasmodium berghei Apical Membrane Antigen 1 or Microneme Protein Enhances Protection against P. berghei Infection in Mice
por: Kim, Min-Ju, et al.
Publicado: (2022)

Protective Immunity Induced by Virus-Like Particle Containing Merozoite Surface Protein 9 of Plasmodium berghei
por: Lee, Su-Hwa, et al.
Publicado: (2020)

Simple and rapid plaque assay for recombinant baculoviruses expressing influenza hemagglutinin
por: Basak, Swarnendu, et al.
Publicado: (2021)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
por: Braz Gomes, Kimberly, et al.
Publicado: (2021)

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
por: Gomes, Keegan Braz, et al.
Publicado: (2022)

Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses
por: Lee, Su-Hwa, et al.
Publicado: (2019)

Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
por: Lee, Su-Hwa, et al.
Publicado: (2022)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations
por: Kang, Hae-Ji, et al.
Publicado: (2020)

Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen
por: Kim, Min-Ju, et al.
Publicado: (2021)

Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium berghei
por: Lee, Dong-Hun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f890fe3lucd8g0bqds8u1g8ren